Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Ketamine Infusion for Social Anxiety Disorder [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial of ketamine infusion for social anxiety disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Social Anxiety Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-03-18